Cargando…
Estrogen-regulated feedback loop limits the efficacy of estrogen receptor–targeted breast cancer therapy
Endocrine therapy resistance invariably develops in advanced estrogen receptor-positive (ER(+)) breast cancer, but the underlying mechanisms are largely unknown. We have identified C-terminal SRC kinase (CSK) as a critical node in a previously unappreciated negative feedback loop that limits the eff...
Autores principales: | Xiao, Tengfei, Li, Wei, Wang, Xiaoqing, Xu, Han, Yang, Jixin, Wu, Qiu, Huang, Ying, Geradts, Joseph, Jiang, Peng, Fei, Teng, Chi, David, Zang, Chongzhi, Liao, Qi, Rennhack, Jonathan, Andrechek, Eran, Li, Nanlin, Detre, Simone, Dowsett, Mitchell, Jeselsohn, Rinath M., Liu, X. Shirley, Brown, Myles |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
National Academy of Sciences
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6077722/ https://www.ncbi.nlm.nih.gov/pubmed/29987050 http://dx.doi.org/10.1073/pnas.1722617115 |
Ejemplares similares
-
Oral Selective Estrogen Receptor Degraders (SERDs) in Breast Cancer: Advances, Challenges, and Current Status
por: Downton, Teesha, et al.
Publicado: (2022) -
How drug resistance takes shape
por: Jeselsohn, Rinath, et al.
Publicado: (2016) -
Conserved E2F mediated metastasis in mouse models of breast cancer and HER2 positive patients
por: Rennhack, Jonathan, et al.
Publicado: (2015) -
Low E2F2 activity is associated with high genomic instability and PARPi resistance
por: Rennhack, Jonathan P., et al.
Publicado: (2020) -
Mathematical Modeling Identifies Optimum Palbociclib-fulvestrant Dose Administration Schedules for the Treatment of Patients with Estrogen Receptor–positive Breast Cancer
por: Cheng, Yu-Chen, et al.
Publicado: (2023)